NorthWest Biotherapeutics Inc (NWBO)

[Roman516]

The trial was inferred, implied as adaptive.
Interesting, since Dr. Linda Liau has previously been involved in what is referred to as adaptative process "TMIC-16. TUMOR-INFILTRATING MYELOID CELLS MEDIATE ADAPTIVE IMMUNE RESISTANCE IN GLIOBLASTOMA"

https://academic.oup.com/neuro-oncology/article/18/suppl_6/vi203/2543434

https://neurotree.org/beta/publications.php?pid=74524

Since the word "adaptive is an adjective", a word belonging to one of the major form classes in any of numerous languages and typically serving as a modifier of a noun to denote a quality of the thing named, to indicate its quantity or extent, or to specify a thing as distinct from something else.
So, the 2018 publication that Dr. Linda Liau does not mention the word adaptive
https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-018-1507-6
However, the adaptive process is in fact implied based on the content of the publication since it includes "denote a quality of the thing named, to indicate its quantity or extent, or to specify a thing as distinct from something else"

Thanks for making this evident once again it supports Dr. Linda Liau and NWBO's effort to make a positive and effective treatment for nGBM and rGBM brain canc